Literature DB >> 6183185

'Carcinoid' tumours of the breast: the morphological spectrum of argyrophil carcinomas.

J G Azzopardi, P Muretto, P Goddeeris, V Eusebi, J M Lauweryns.   

Abstract

Fourteen 'carcinoid' tumours of the breast are described. They are separable into five with and nine without intracellular mucin. All the tumours are argyrophil, but none is argentaffin. Four tumours studied ultrastructurally contain dense-core granules. Argyrophil carcinomas represent the endocrine analogues of ductal carcinoma in situ, of invasive ductal carcinoma and probably of lobular carcinoma also. Current views vary between the one that the so-called carcinoid is a rare and totally distinct entity to the view, at the other extreme, that it is a very common variant of conventional breast cancer. On the basis of our findings, an intermediate view is justified: argyrophil carcinomas constitute about 5% of breast carcinomas and some varieties at least have non-argyrophil analogues. Factors influencing the prognosis in individual cases are discussed. Argyrophil carcinomas of the breast form a tumour spectrum with a wide range of morphological and histochemical appearances and a variable prognosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183185     DOI: 10.1111/j.1365-2559.1982.tb02750.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  20 in total

1.  Fine Needle Aspiration Cytology of Argyrophilic Mucinous Carcinoma of the Male Breast.

Authors: 
Journal:  Breast Cancer       Date:  1996-03-29       Impact factor: 4.239

2.  Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast.

Authors:  Libo Yang; Madhuchhanda Roy; Heather Lin; Yu Shen; Constance Albarracin; Lei Huo; Hui Chen; Bing Wei; Isabelle Bedrosian; Hong Bu; Yun Wu
Journal:  Breast Cancer Res Treat       Date:  2021-02-02       Impact factor: 4.872

3.  Sex steroid receptor expression in 'carcinoid' tumours of the breast.

Authors:  C A Birsak; P J Janssen; C C van Vroonhoven; J L Peterse; T H van der Kwast
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Per operative localization of a carcinoid tumour of the breast using indium-111 pentetreotide and a nuclear surgical probe.

Authors:  B Meunier; J Le Cloirec; L Dazord; J Leveque; T Lesimple; P Tas; P Bourguet
Journal:  Eur J Nucl Med       Date:  1995-03

Review 5.  Primary neuroendocrine breast cancer, how much do we know so far?

Authors:  Homam Alkaied; Kassem Harris; Basem Azab; Qun Dai
Journal:  Med Oncol       Date:  2012-04-01       Impact factor: 3.064

6.  Metastatic carcinoid presenting as a breast lesion.

Authors:  H L Geyer; J Viney; N Karlin
Journal:  Curr Oncol       Date:  2010-11       Impact factor: 3.677

7.  A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy.

Authors:  Xiaolong Wei; Chunfa Chen; Didi Xi; Jinwen Bai; Wenhe Huang; Luoxiang Rong; Mingyao Wu; Guojun Zhang
Journal:  Front Med       Date:  2014-08-06       Impact factor: 4.592

Review 8.  Carcinomas of the breast with endocrine differentiation: a review.

Authors:  H M Maluf; F C Koerner
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 9.  Working formulation of neuroendocrine tumors of the skin and breast.

Authors:  Sofia Asioli; Maria Pia Foschini; Riccardo Masetti; Vincenzo Eusebi
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

10.  Chromogranin A and B gene expression in carcinomas of the breast. Correlation of immunocytochemical, immunoblot, and hybridization analyses.

Authors:  A Pagani; M Papotti; H Höfler; R Weiler; H Winkler; G Bussolati
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.